Robin Everts

Robin Everts is a scientist and researcher with expertise in animal genetics and breeding. He is currently serving as a Guest Editor for the Animals Special Issue on Advances in Equine Genetics and Breeding.12

Professional Background

Robin Everts holds the following positions:

• Head of Research & Development at Etalon Inc. in Menlo Park, California (since January 2023)1
• Scientific Advisor at ADx Health (since June 2022)1

Education and Early Career

• MSc in Animal Sciences from Wageningen Agricultural University, The Netherlands (1995)1
• PhD from the Department of Veterinary Medicine, Universiteit Utrecht, The Netherlands (2000)1
• Conducted research in embryo/fetal functional genomics at the University of Illinois at Urbana-Champaign (2000-2007)1

Industry Experience

• Worked at Sequenom Bioschiences, Inc. in various roles (2007-2014)1
• Joined Agena Bioscience, Inc. in San Diego, CA in 2014, where he was responsible for Pharmacogenetics assay development1

Research and Publications

Dr. Everts is the (co-)author of 48 peer-reviewed papers.1 His areas of expertise include:

• SNP and genotyping
• Assay development
• Pharmacogenomics
• Copy number variation (CNV)
• Animal genomics
• Cancer mutation screening
• Microarray gene expression analysis
• Bioinformatics

Current Role as Guest Editor

As a Guest Editor for the Animals Special Issue on Advances in Equine Genetics and Breeding, Dr. Everts is overseeing the collection of research on various aspects of horse genetics, breeding, and reproduction.2 The special issue aims to provide insights into genetic mechanisms underlying complex traits in horses and new approaches to improve horse breeding.2